Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biológicos Estratégicos Bioest S A S has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit, so the recorded activity is concentrated. WRIGHT, SARAH C is the busiest examiner, with 1 pending matter.
This profile gives counsel a single examination context for reviewing the outstanding issue. No additional examiner or art-unit assignment is recorded, which limits the need for portfolio-wide coordination. The practical focus is an examiner-specific response that keeps claim scope and technical support aligned with the biotechnology and pharmaceutical disclosure.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, SARAH C | 1 | 42.1% | +45.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17773579 | GREEN ANTIFUNGAL AGROCHEMICAL FORMULATION BASED ON NANOMATERIALS OF SILICON AND ZINC | WRIGHT, SARAH C | 56d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17773579 | GREEN ANTIFUNGAL AGROCHEMICAL FORMULATION BASED ON NANOMATERIALS OF SILICON AND ZINC | WRIGHT, SARAH C | 56d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17773579 | GREEN ANTIFUNGAL AGROCHEMICAL FORMULATION BASED ON NANOMATERIALS OF SILICON AND ZINC | WRIGHT, SARAH C | 1619 | §103§112 | Final Rejection | 56d | Pending | Apr 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiológicos Estratégicos Bioest S A S has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sarah C Wright has the most, with 1 of Biológicos Estratégicos Bioest S A S's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
